Redmile Group, LLC sold ADCT
April 2, 2026 · Form 4 insider transaction
Redmile Group, LLC sold 2,529,491 shares of ADC Therapeutics SA at $3.28 per share, a transaction worth $8.29M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,529,491
Price
$3.28
Total value
$8.29M
InsiderRedmile Group, LLC
Role—
CompanyADC Therapeutics SA (ADCT)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateApril 2, 2026
Filing dateApril 2, 2026
Shares owned after10,265,297
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.25 to $3.77, inclusive. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price.; These securities are directly owned by RedCo II Master Fund, L.P.